Jury Sides With Pitt In $37M Radiation Patent Row With Varian

Law360, New York (April 18, 2012, 7:04 PM EDT) -- A Pennsylvania federal jury on Wednesday upheld a patent for a cancer-treatment device owned by the University of Pittsburgh, leaving Varian Medical Systems Inc. facing $37 million in potential damages as a result of its infringement.

In upholding the validity of the school's patent, the jury closed out the third of three separate trials set up after the Pennsylvania court determined that oncology and X-ray imaging systems manufacturer Varian was liable for infringement. Varian had argued that the patent was invalid.

Representatives for the parties were...
To view the full article, register now.